Olaf Doehr is a Due Diligence Expert in Non-clinical Safety at Bayer Pharmaceuticals, a position they have held since 2019. Prior to this, they worked as a Project Toxicologist at Bayer from 2008 to 2019 and as a Senior Project Toxicologist at Actelion from 2006 to 2008. Olaf's earlier experience includes a role as Nonclinical Director at Silence Therapeutics plc and as a Toxicologist at Schering. They completed a postdoctoral fellowship at the University of Dundee in biomedical research and are currently pursuing a PhD in Biology/Toxicology at Universität Düsseldorf.
This person is not in the org chart
This person is not in any teams
This person is not in any offices